| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |